Gene: LBR
Official Full Name: lamin B receptorprovided by HGNC
Gene Summary: The protein encoded by this gene belongs to the ERG4/ERG24 family. It localized in the nuclear envelope inner membrane and anchors the lamina and the heterochromatin to the membrane. It may mediate interaction between chromatin and lamin B. Mutations of this gene has been associated with autosomal recessive HEM/Greenberg skeletal dysplasia. Alternative splicing occurs at this locus and two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06436 | LBR Knockout cell line (HeLa) | Human | LBR | 1:3~1:6 | Negative | Online Inquiry |
KO06437 | LBR Knockout cell line (HCT 116) | Human | LBR | 1:2~1:4 | Negative | Online Inquiry |
KO06438 | LBR Knockout cell line (HEK293) | Human | LBR | 1:3~1:6 | Negative | Online Inquiry |
KO06439 | LBR Knockout cell line (A549) | Human | LBR | 1:3~1:4 | Negative | Online Inquiry |
LBR Gene Knockout Cell Lines are advanced biotechnological tools designed to facilitate the functional analysis of the LBR (Lamin B Receptor) gene by selectively disrupting its expression. These cell lines are engineered through CRISPR-Cas9 technology, which allows for precise genomic alterations, thereby enabling researchers to investigate the endogenous functions of the LBR gene within a cellular context. The generation of knockout models is critical for understanding gene function, cellular pathways, and the implications of genetic variations on phenotypic outcomes.
The key mechanism of LBR Gene Knockout Cell Lines revolves around the targeted approach of knocking out specific areas of the genome, leading to the elimination of the LBR protein. This results in a range of observable cellular phenotypes that can elucidate the broader implications of LBR function in processes such as chromatin organization, nuclear integrity, and regulation of gene expression. Detailed studies using these knockout lines have applications in cancer research, developmental biology, and the exploration of neurological diseases, where LBR's role may be pivotal.
In terms of scientific importance, LBR Gene Knockout Cell Lines offer researchers the opportunity to explore previously uncharacterized pathways and gene interactions. Compared to traditional knockdown methods, such as siRNA or shRNA, these knockout cell lines provide a more permanent and comprehensive loss of function. This permanence allows for improved reproducibility and clearer results in functional studies.
The unique selling points of the LBR Gene Knockout Cell Lines include their precise genome editing capabilities, the ability to generate multiple clones with consistent performance, and the expansive potential for downstream experiments, such as drug screening and protein characterization. Additionally, these cell lines can serve as a foundation for creating animal models, further bridging the gap between in vitro and in vivo studies.
Researchers and clinicians will find immense value in the LBR Gene Knockout Cell Lines due to their robustness and versatility, enabling deeper insights into gene functions that could lead to novel therapeutic strategies. With a commitment to advancing biological research, our company leverages extensive expertise in gene editing technologies to deliver high-quality, reliable products that meet the rigorous demands of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.